Oxford Biomedica, (OXB). Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Biomedica, (OXB).

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Oily1 who started this subject	6/7/2004 1:20:27 PM
From: Oily1	of 111

Acquisition :- Oxford Biomedica PLC said it has signed an agreement with Chiron Corporation to acquire certain patent families from Chiron's gene therapy patent portfolio. The agreement includes taking assignment of Chiron's interest in a license agreement with an undisclosed university. Financial terms have not been disclosed. Chiron's patent portfolio contains some early gene therapy technology that complements Oxford BioMedica's substantial gene therapy patent estate, it said. Under a separate deal Chiron has made an equity investment in Oxford BioMedica subscribing for a total of 316,026 ordinary shares of 1p each at 17.23 pence per share. rn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next